Publications

Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective.

J. Rheumatol.
Harrold LR, Andrade SE, Go AS, Buist AS, Eisner M, Vollmer WM, Chan KA, Frazier EA, Weller PF, Wechsler ME, Yood RA, Davis KJ, Platt R

Opportunity knocks: the electronic (public health) medical record.

Epidemiology
Platt R

Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004.

Pediatrics
Huang SS, Platt R, Rifas-Shiman SL, Pelton SI, Goldmann D, Finkelstein JA

Frequency of high-risk use of QT-prolonging medications.

Pharmacoepidemiol Drug Saf
Allen LaPointe NM, Curtis LH, Chan KA, Kramer JM, Lafata JE, Gurwitz JH, Raebel MA, Platt R

Simulated anthrax attacks and syndromic surveillance.

Emerging Infect. Dis.
Nordin JD, Goodman MJ, Kulldorff M, Ritzwoller DP, Abrams AM, Kleinman K, Levitt MJ, Donahue J, Platt R

A beneficial side effect of the Medicare drug benefit.

N. Engl. J. Med.
Platt R, Ommaya A

Infection control practices to reduce airborne bacteria during total knee replacement: a hospital survey in four states.

Infect Control Hosp Epidemiol
Miner AL, Losina E, Katz JN, Fossel AH, Platt R

Laboratory monitoring of drugs at initiation of therapy in ambulatory care.

J Gen Intern Med
Raebel MA, Lyons EE, Andrade SE, Chan KA, Chester EA, Davis RL, Ellis JL, Feldstein A, Gunter MJ, Lafata JE, Long CL, Magid DJ, Selby JV, Simon SR, Platt R

Evaluating spatial surveillance: detection of known outbreaks in real data.

Stat Med
Kleinman K, Abrams A, Katherine Yih W, Platt R, Kulldorff M

Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.

Pharmacoepidemiol Drug Saf
Raebel MA, McClure DL, Simon SR, Chan KA, Feldstein A, Andrade SE, Lafata JE, Roblin D, Davis RL, Gunter MJ, Platt R

Monitoring patient safety in health care: building the case for surrogate measures.

Jt Comm J Qual Patient Saf
Gaynes RP, Platt R

Use of prescription medications with a potential for fetal harm among pregnant women.

Pharmacoepidemiol Drug Saf
Andrade SE, Raebel MA, Morse AN, Davis RL, Chan KA, Finkelstein JA, Fortman KK, McPhillips H, Roblin D, Smith DH, Yood MU, Platt R, H Gurwitz J

The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis.

Vaccine
Sinha A, Lieu TA, Paoletti LC, Weinstein MC, Platt R

Potential drug-drug interactions in the outpatient setting.

Med Care
Lafata JE, Schultz L, Simpkins J, Chan KA, Horn JR, Kaatz S, Long C, Platt R, Raebel MA, Smith DH, Xi H, Yood MU

Risk factors for statin-associated rhabdomyolysis.

Pharmacoepidemiol Drug Saf
Schech S, Graham D, Staffa J, Andrade SE, La Grenade L, Burgess M, Blough D, Stergachis A, Chan KA, Platt R, Shatin D

Risk of acquiring antibiotic-resistant bacteria from prior room occupants.

Arch. Intern. Med.
Huang SS, Datta R, Platt R

Asthma drug use and the development of Churg-Strauss syndrome (CSS).

Pharmacoepidemiol Drug Saf
Harrold LR, Patterson MK, Andrade SE, Dube T, Go AS, Buist AS, Chan KA, Weller PF, Wechsler ME, Yood RA, Davis KJ, Platt R, Walker AM

Ethics, regulation, and comparative effectiveness research: time for a change.

JAMA
Platt R, Kass NE, McGraw D

Simulation shows hospitals that cooperate on infection control obtain better results than hospitals acting alone.

Health Aff (Millwood)
Lee BY, Bartsch SM, Wong KF, Yilmaz SL, Avery TR, Singh A, Song Y, Kim DS, Brown ST, Potter MA, Platt R, Huang SS

Multivariate scan statistics for disease surveillance.

Stat Med
Kulldorff M, Mostashari F, Duczmal L, Katherine Yih W, Kleinman K, Platt R